Edwards Lifesciences drops 'coppycat' policy to provide 'clarity' in EU probe
MLex Summary: Edwards Lifesciences said it had removed a problematic policy governing "copycat" producers of heart-valve products "with a view to providing clarity" in the context of an EU antitrust investigation. The...To view the full article, register now.
Already a subscriber? Click here to view full article